Management of hepatocellular carcinoma: an update
- PMID: 21374666
- PMCID: PMC3084991
- DOI: 10.1002/hep.24199
Management of hepatocellular carcinoma: an update
Figures


Comment in
-
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases.Hepatology. 2011 Mar;53(3):1060-1; author reply 1061-2. doi: 10.1002/hep.24033. Epub 2010 Dec 28. Hepatology. 2011. PMID: 21374678 No abstract available.
-
Updated management of hepatocellular carcinoma.Hepatology. 2011 Sep 2;54(3):1113. doi: 10.1002/hep.24378. Epub 2011 Jul 21. Hepatology. 2011. PMID: 21520202 No abstract available.
-
Postoperative transcatheter arterial chemoembolization should be recommended in the hepatocellular carcinoma treatment guidelines of the American Association for the Study of Liver Diseases.Hepatology. 2011 Oct;54(4):1489-90. doi: 10.1002/hep.24446. Epub 2011 Jul 21. Hepatology. 2011. PMID: 21618569 No abstract available.
References
-
- Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50:80–88. - PubMed
-
- Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, et al. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol. 2010;28:2437–2444. - PubMed
-
- Yeoman AD, Al-Chalabi T, Karani JB, Quaglia A, Devlin J, Mieli-Vergani G, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology. 2008;48:863–870. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical